title: Reply: A persisting dilemma for triple antithrombotic therapy: are we close to finding the correct answer?
authors: Morten
authors: M
authors: Lamberts
authors: Gunnar H
authors: GH
authors: Gislason
authors: Jonas Bjerring
authors: JB
authors: Olesen
authors: Søren Lund
authors: SL
authors: Kristensen
authors: Anne-Marie
authors: AM
authors: Schjerning Olsen
authors: Anders
authors: A
authors: Mikkelsen
authors: Christine Benn
authors: CB
authors: Christensen
authors: Gregory Y H
authors: GY
authors: Lip
authors: Lars
authors: L
authors: Køber
authors: Christian
authors: C
authors: Torp-Pedersen
authors: Morten Lock
authors: ML
authors: Hansen
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000517:prevention & control*; D062645:Percutaneous Coronary Intervention; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011183:Postoperative Complications
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors